News
-
09.02.2010
Debiopharm Group™ grants an exclusive licence for the development, manufacture and commercialisation of Debio 025 - A potent, first-in-class antiviral agent for the treatment of Hepatitis C - -
04.02.2010
Launch of Ipsen’s Decapeptyl® 6-month formulation (LP 22.5 mg) in France for the treatment of locally advanced or metastatic hormone-dependent prostate cancer
Home
| Careers |
Our PeopleApproximately 300 people of more than 18 nationalities are employed at Debiopharm Group worldwide - including Switzerland, France and China. Our people have a high level of science education with 42 % scientists (MDs, PhDs, pharmacists). In addition to our internal expertise, we also work with an extensive international network of experts, enabling us to tap into top-level scientific, development and business capabilities. Positions with DebiopharmWe are an international group of companies and we strive to recruit highly competent, flexible and hard-working people for each position. We currently have the following openings:Lausanne Click here for a spontaneous job application. Martigny Click here for a spontaneous job application. Paris Click here for a spontaneous job application. |